Insulin/IGF-1 modulation of the expression of two estrogen-induced genes in MCF-7 cells

Molecular and Cellular Endocrinology

Volumn 121, Issue 1, 1996, Pages 29-35

  El Tanani, M K K ^a   Green, C D ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Estrogen; Insulin; LIV 1; MCF 7; pS2

Indexed keywords

ANTIESTROGEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; INSULIN; MESSENGER RNA; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; SOMATOMEDIN C;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; GENE INDUCTION; HORMONAL REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TRANSCRIPTION REGULATION;

EID: 0030598648     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/0303-7207(96)03844-0     Document Type: Article

References (34)

1. [1] Vonderhaar, B.K. (1984) Hormones and growth factors in mammary gland development. In: Control of Cell Growth and Proliferation (Venziale, C.M., ed.), pp. 11-33. Van Nostrand Reinhold, New York.
2. [2] Vonderhaar, B.K. and Ziska, S.E. (1989) Hormonal regulation of milk protein gene expression. Annu. Rev. Physiol. 51, 641-652.
3. [3] Henderson, I.C. and Canellos, G.P. (1979) Cancer of the breast. N. Engl. J. Med. 302, 17-30.
4. [4] Lippman, M.E., Bolan, G. and Huff, K. (1976) The effects of estrogens and antiestrogens on hormone responsive human breast cancer in long-term culture. Cancer Res. 36, 4595-4601.
5. [5] Osborne, C.K., Hobbs, K. and Clark, G.M. (1985) Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res. 45, 584-590.
6. [6] van den Berg, B., Rutteman, G.R., Blankenstein, M.A., Delaar, S.W. and van Zoelen, J.J. (1988) Mitogenic stimulation of human breast cancer in a growth factor defined medium: synergistic action of insulin and estrogen. J. Cell. Physiol. 134, 101-108.
7. [7] Katzenellenbogen, B.S. and Norman, M.J. (1990) Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: interrelationships among insulin insulin-like growth factor-I, serum and estrogen. Endocrinology 126, 891-898.
8. [8] Kumar, V., Green, S., Stack, G., Berry, M., Jin, J.R. and Chambon, P. (1987) Functional domains of the human estrogen receptor. Cell, 51, 941-951.
9. [9] Rothenberg, P., White, M.F. and Kahn, C. R. (1990) The insulin receptor tyrosine kinase. In: The Handbook of Experimental Pharmacology, Insulin (Cuatracasas, P. and Jacob, S., eds.), pp. 169-181. Springer-Verlag, New York.
10. [10] Roth, R.A., Zhang, B., Chin, J.E. and Kovacina, K. (1992) Substrates and signalling complexes: The tortured path to insulin action. J. Cell. Biochem. 48, 12-18.
11. [11] Meisler, M.H. and Howard, G. (1989) Effects of insulin on gene transcription. Annu. Rev. Physiol. 51, 701-714.
12. [12] Manning, D.E., Daly, R.J., Lord, P.G., Kelly, K.F. and Green, C.D. (1988) Effects of oestrogen on the expression of a 4.4kb mRNA in the ZR-75-1 human breast cancer cell line. Mol. Cell. Endocrinol. 59, 205-212.
13. [13] Masiakowski, P., Breathnach, R., Bloch, J., Gannon, F., Krust, A. and Chambon, P. (1982) Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res. 10, 7895-7903.
14. [14] El-Tanani, M.K.K. and Green, C.D. (1995) Oestrogen-induced genes, pLIV-1 and pS2, respond divergently to other steroid hormones in MCF-7 cells. Mol. Cell. Endocrinol. 111, 75-81.
15. [15] Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A. and Struhl, K. (1989) Current Protocols in Molecular Biology, Vol. 1, p. 4.10.1, Wiley Interscience, New York.
16. [16] Lippman, M.E., Bolan, G. and Huff, K. (1976) The effects of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term culture. Cancer Res. 36, 4602-4609.
17. [17] Lippman, M.E., Bolan, G. and Huff, K. (1976) The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term culture. Cancer Res. 36, 4610-4618.
18. [18] Horwitz, K.B. and McGuire, W.L. (1978) Estrogen control of progesterone receptor in human breast cancer. J. Biol. Chem. 253, 2223-2228.
19. [19] Parker, M.G., Arbuckle, N., Dauvois, S., Danielian, P. and White, R. (1993) Structure and function of the estrogen receptor. Ann. N. Y. Acad. Sci. 684, 119-126.
20. [20] Johnson, T.M., Rosenberg, M.P. and Meisler, M.H. (1993) An insulin-responsive element in the pancreatic enhancer of the amylase gene. J. Biol. Chem. 268, 464-468.
21. [21] Suwanickul, A., Morris, S.L. and Powell, D.R. (1993) Identification of an insulin-responsive clement in the promoter of the human gene for insulin-like growth factor binding protein-I. J. Biol. Chem. 268, 17063-17068.
22. [22] Kimball, S.R., Vary, T.C. and Jefferson, L.S. (1994) Regulation of protein synthesis by insulin. Annu. Rev. Physiol. 56, 321-348.
23. [23] Paulauskis, J.D. and Sul, H.S. (1989) Hormonal regulation of mouse fatty acid synthase gene transcription in liver. J. Biol. Chem. 264, 574-577.
24. [24] Wakeling, A.E. and Bowler, J. (1988) Novel antioestrogens without partial agonist activity. J. Steroid Biochem. 31, 645-653.
25. [25] Weatherill, P.J., Wilson, A.P.M., Nicholson, R.I., Davies, P. and Wakeling, A.E. (1988) Interactions of the antioestrogen ICI 164384 with the oestrogen receptor. J. Steroid. Biochem. 30, 263-266.
26. [26] Wilson, A.P.M., Weatherill, P.J., Nicholson, R.I., Davies, P. and Wakeling, A.E. (1990) A comparative study of the interaction of oestradiol and the steroidal pure antoestrogen, ICI 164384, with the molybdate-stabilized oestrogen receptor. J. Steroid Biochem. 35, 421-428.
27. [27] Arbuckle, N.D.S., Dauvois, S. and Parker, M.G. (1992) Effects of antioestrogens on the DNA binding activity of oestrogen receptors in vitro. Nucleic Acids Res. 20, 3839-3844.
28. [28] Fawell, S.E., White, R., Hoare, S., Sydenham, M., Page, M. and Parker, M.G. (1990) Inhibition of estrogen receptor-DNA binding by the 'pure' antiestrogen ICI 164384 appears to be mediated by impaired receptor dimerization. Proc. Natl. Acad. Sci. USA 87, 6883-6887.
29. [29] Sabbah, M., Gouilleux, F., Soal, B., Redeuilh, G. and Baulieu, E-E. (1991) Structural differences between the hormone and antihormone estrogen receptor complexes bound to the hormone response element. Proc. Natl. Acad. Sci. USA 88, 390-394.
30. [30] Dauvois, S., Danielian, P.S., White, R. and Parker, M.G. (1992) Antiestrogen ICI 164384 reduces cellular estrogen receptor content by increasing its turnover. Proc. Natl. Acad. Sci. USA 89, 4037-4041.
31. [31] Ignar-Trowbridge, D.M., Nelson, K.G., Bidwell, M.C., Curtis, S.W., Washburn, T.F., McLachlan, J.A. and Korach, K.S. (1992) Coupling of dual signaling pathways: Epidermal growth factor action involves the estrogen receptor. Proc. Natl. Acad. Sci. USA 89, 4658-4662.
32. [32] Ignar-Trowbridge, D.M., Teng, C.T., Ross, K.A., Parker, M.G., Korach, K.S. and McLachlan, J.A. (1993) Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol. Endocrinol. 7, 992-998.
33. [33] Chalbos, D., Philips, A., Galtier, F. and Rochefort, H. (1993) Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger RNA by growth factors and adenosine 3′5′-monophosphate in MCF7 cells. Endocrinology 133, 571-576.
34. [34] Meyer, M-E., Gronemeyer, H., Turcotte, B., Bocquel, M-T., Tasset, D. and Chambon, P. 1989 Steroid hormone receptors compete for factors that mediate their enhancer function. Cell, 57, 433-442.